C07D 311/58
Other than with oxygen or sulphur atoms in position 2 or 4
Official title: other than with oxygen or sulphur atoms in position 2 or 4
C07D311/58 (Other than with oxygen or sulphur atoms in position 2 or 4) appears on 1,939 US grants and 1,409 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,939
- Published applications
- 1,409
- Assignees
- 907
- Inventors
- 4,938
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 14 | 0 |
| 1978 | 33 | 0 |
| 1979 | 24 | 0 |
| 1980 | 31 | 0 |
| 1981 | 19 | 0 |
| 1982 | 18 | 0 |
| 1983 | 13 | 0 |
| 1984 | 19 | 0 |
| 1985 | 27 | 0 |
| 1986 | 29 | 0 |
| 1987 | 39 | 0 |
| 1988 | 26 | 0 |
| 1989 | 39 | 0 |
| 1990 | 40 | 0 |
| 1991 | 36 | 0 |
| 1992 | 42 | 0 |
| 1993 | 36 | 0 |
| 1994 | 43 | 0 |
| 1995 | 44 | 0 |
| 1996 | 49 | 0 |
| 1997 | 77 | 0 |
| 1998 | 60 | 0 |
| 1999 | 65 | 0 |
| 2000 | 63 | 0 |
| 2001 | 38 | 8 |
| 2002 | 62 | 45 |
| 2003 | 51 | 85 |
| 2004 | 44 | 87 |
| 2005 | 39 | 84 |
| 2006 | 50 | 84 |
| 2007 | 26 | 62 |
| 2008 | 37 | 64 |
| 2009 | 39 | 58 |
| 2010 | 54 | 63 |
| 2011 | 50 | 48 |
| 2012 | 48 | 44 |
| 2013 | 49 | 58 |
| 2014 | 41 | 62 |
| 2015 | 62 | 64 |
| 2016 | 47 | 59 |
| 2017 | 45 | 46 |
| 2018 | 34 | 45 |
| 2019 | 42 | 32 |
| 2020 | 30 | 52 |
| 2021 | 34 | 56 |
| 2022 | 35 | 49 |
| 2023 | 27 | 39 |
| 2024 | 18 | 53 |
| 2025 | 26 | 34 |
| 2026 | 15 | 28 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07D 311/70With two hydrocarbon radicals attached in position 2 and elements other than582
- C07D 311/60With aryl radicals attached in position 2317
- C07D 311/68With nitrogen atoms directly attached in position 4195
- C07D 311/66With carbon atoms having three bonds to hetero atoms with at the125
- C07D 311/64With oxygen atoms directly attached in position 896
Recent patents
- Ring closure of benzoquinones containing an unsaturated side chain using a basic catalyst8 Sep 2026US 12,729,188 B2Dsm IP Assets B.V.
- Crystalline form of epigallocatechin-3-gallate1 Sep 2026US 12,723,034 B2PharmassětX Inc.
- Anti-inflammatory carboxamide derivatives21 Jul 2026US 12,686,657 B2Biomedcode Hellas SA
- Synthesis of small molecules inspired by phomoxanthone A9 Jun 2026US 12,649,725 B2Worcester Polytechnic Institute
- Flavanone derivatives and their use as sweetness enhancers26 May 2026US 12,635,718 B2
- Crystalline form of epigallocatechin-3-gallate1 Oct 2026US 2026/0297048 A1PharmassětX Inc.
- Crystalline form of epigallocatechin-3-gallate1 Oct 2026US 2026/0297049 A1PharmassětX Inc.
- Crystalline form of epigallocatechin-3-gallate1 Oct 2026US 2026/0297050 A1PharmassětX Inc.
- Compounds for positive modulation of the autophagy-lysosomal pathway and methods of use27 Aug 2026US 2026/0250256 A1
- Production of terpenoids, phenolic compounds, and vitamins from yeast family trichosporonaceae27 Aug 2026US 2026/0250719 A1Technische Universität München
Most cited
By later US patents
- Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity220US 5,089,509 AAllergan, Inc. · 1992
- Gas phase polymerization process167US 5,453,471 AUnion Carbide Chemicals & Plastics Technology Corporation · 1995
- Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities164US 5,877,207 AAllergan Sales, Inc. · 1999
- Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity158US 5,023,341 AAllergan, Inc. · 1991
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009